Showing results (231-240 of 248) with videos related to

Sort By:
Pageof 25
Journal of Immunology (Baltimore, Md. : 1950)|November 19, 2013
Differences in the phenotype, cytokine gene expression profiles, and in vivo alloreactivity of T cells mobilized with plerixafor compared with G-CSFAndreas Lundqvist, Aleah L Smith, Yoshiyuki Takahashi, et al.
Diabetologia|December 3, 2017
Combinatorial detection of autoreactive CD8+ T cells with HLA-A2 multimers: a multi-centre study by the Immunology of Diabetes Society T Cell WorkshopEddie A James, Joana R F Abreu, John W McGinty, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2010
Second generation 2-pyridyl biphenyl amide inhibitors of the hedgehog pathwayGeorgette M Castanedo, Shumei Wang, Kirk D Robarge, et al.
Frontiers in Immunology|November 1, 2023
Single-cell RNAseq identifies clonally expanded antigen-specific T-cells following intradermal injection of gold nanoparticles loaded with diabetes autoantigen in humansStephanie J Hanna, Terri C Thayer, Emma J S Robinson, et al.
Scientific Reports|October 18, 2016
Targeted suppression of autoreactive CD8+ T-cell activation using blocking anti-CD8 antibodiesMathew Clement, James A Pearson, Stephanie Gras, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2010
Identification of GNE-477, a potent and efficacious dual PI3K/mTOR inhibitorTimothy P Heffron, Megan Berry, Georgette Castanedo, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 12, 2011
Significant species difference in amide hydrolysis of GDC-0834, a novel potent and selective Bruton's tyrosine kinase inhibitorLichuan Liu, Jason S Halladay, Young Shin, et al.
Science Advances|January 4, 2023
Spleen tyrosine kinase inhibition restores myeloid homeostasis in COVID-19Gustaf Wigerblad, Seth A Warner, Marcos J Ramos-Benitez, et al.
Journal of Medicinal Chemistry|January 7, 2010
Discovery of (thienopyrimidin-2-yl)aminopyrimidines as potent, selective, and orally available pan-PI3-kinase and dual pan-PI3-kinase/mTOR inhibitors for the treatment of cancerDaniel P Sutherlin, Deepak Sampath, Megan Berry, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2023
Filling a nick in NIK: Extending the half-life of a NIK inhibitor through structure-based drug designJames J Crawford, Jianwen Feng, Hans D Brightbill, et al.
Pageof 25